New award for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Period of performance is november 1, 2020 through october 31, 2021 with four one year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79720D0068
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$2,635,810.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Glenmark Pharmaceuticals Inc., USA, a foreign-owned, for-profit pharmaceutical company. The contract has a total ceiling value of $2,635,810 and a period of performance from November 1, 2020 through October 31, 2021, with four one-year option periods.

The purpose of this IDC is to provide an uninterrupted source of supply for aprepitant capsules to serve the pharmaceutical needs of the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The contract items will be distributed through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. The contracted products include various package sizes and strengths of aprepitant capsules, with estimated annual usage quantities provided in the original solicitation. This contract leverages Glenmark's existing federal supply schedule and IDC vehicles to supply branded and generic pharmaceutical products to key federal healthcare agencies.

Transactions

Action Obligated Date
Add Subcontract Plan P00017 · 2026 subcontracting plan effective 4/1/2025 through 3/31/2026 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Exercise an Option P00016 · Exercise option year 4 effective 11/1/2024 through 10/31/2025 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Prices remain unchanged. $0
Add Subcontract Plan P00015 · 2024 subcontracting plan effective 4/1/2024 through 3/31/2025 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Other Administrative Action P00014 · Cancel modification P00013 in its entirety effective 2/26/2024 aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Add Subcontract Plan P00013 · 2024 subcontracting plan effective 4/1/2024 through 3/31/2025 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Other Administrative Action P00012 · Cost recovery fee and submission of quarterly sales report changes effective 2/9/2024 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Prices… $0
Exercise an Option P00011 · Exercise option year 3EFFECTIVE 11/1/2023 to 10/31/2024 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Prices remain unchanged. $0
Other Administrative Action P00010 · Incorporate dscsa effective 5/15/2023 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Add Subcontract Plan P00009 · Incorporate 2023 subcontracting plan effective 4/1/2023 to 3/31/2024 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Prices remain unchanged. $0
Other Administrative Action P00008 · Incorporate contract administrator changes effective 2/15/2023 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Prices remain unchanged. $0
Exercise an Option P00007 · Exercise option year 2 effective november 1, 2022 through october 31, 2023 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Prices remain… $0
Other Administrative Action P00006 · Correct sales report POC changes effective april 14, 2022 through march 31, 2023 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Other Administrative Action P00005 · Incorporate sales report POC changes effective april 13, 2022 through march 31, 2023 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Add Subcontract Plan P00004 · Incorporate 2022 subcontracting plan effective april 1, 2022 through march 31, 2023 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Exercise an Option P00003 · Exercise option year 1 effective november 1, 2021 through october 31, 2022 for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Prices remain… $0
Other Administrative Action P00002 · Administrative changes for aprepitant capsules with glenmark pharmaceuticals, INC., USA. $0
Add Subcontract Plan P00001 · 2021 subcontracting plan for aprepitant capsules with glenmark pharmaceuticals, INC., USA. Period of performance is april 1, 2021 through march 31, 2022. $0
Original award $0
Show all 18

Quick answers

Who was awarded contract 36E79720D0068?

36E79720D0068 was awarded to Glenmark Pharmaceuticals Inc., USA by National Acquisition Center (Headquarters) on November 1, 2020.

How much is contract 36E79720D0068 worth?

36E79720D0068's own ceiling is $2,635,810.

Who can order from contract 36E79720D0068?

36E79720D0068 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 36E79720D0068 competed?

The extent of competition for 36E79720D0068 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV